ArticleCurrent journal of neurology2022

A retrospective study of the safety and efficacy of rituximab in Iranian patients with myasthenia gravis: A single-center experience.

Bentolhoda Ziaadini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.